NCT01866839View on ClinicalTrials.gov

Preventing Stem Cell Transplant Complications With a Blood Separator Machine

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

May 29, 2013

Primary Completion Date

May 23, 2018

Study Completion Date

June 28, 2018

Conditions
MDS (Myelodysplastic Syndrome)Myeloproliferative DisorderLymphoma, Non-HodgkinALL (Acute B-Lymphoblastic Leukemia)AML (Acute Myelogenous Leukemia
Interventions
DEVICE

Graft Manipulation (CD34+ Selection)

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

Sponsors
All Listed Sponsors
collaborator

Children's National Research Institute

OTHER

lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH